Guggenheim Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Guggenheim Capital’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Sell	53,804 -40,883	-43%	-$977K	0.01%	921
2025 Q4	$2.53M	Buy	94,687 +62,565	+195%	+$1.5M	0.02%	606
2025 Q3	$685K	Sell	32,122 -2,062	-6%	-$48.8K	0.01%	1060
2025 Q2	$737K	Sell	34,184 -5,297	-13%	-$98.5K	0.01%	1004
2025 Q1	$656K	Sell	39,481 -748	-2%	-$13.6K	0.01%	1071
2024 Q4	$738K	Sell	40,229 -15,582	-28%	-$251K	0.01%	1067
2024 Q3	$858K	Sell	55,811 -1,106	-2%	-$18.5K	0.01%	1167
2024 Q2	$925K	Buy	56,917 +7,241	+15%	+$117K	0.01%	1163
2024 Q1	$919K	Buy	49,676 +1,517	+3%	+$37.6K	0.01%	1223
2023 Q4	$1.51M	Buy	48,159 +3,158	+7%	+$75.4K	0.01%	969
2023 Q3	$938K	Sell	45,001 -2,835	-6%	-$77K	0.01%	1135
2023 Q2	$1.15M	Sell	47,836 -3,097	-6%	-$68.8K	0.01%	1102
2023 Q1	$959K	Buy	+50,933	New	+$970K	0.01%	1206
2022 Q2	–	Sell	-10,753	Closed	-$261K	–	2043
2022 Q1	$261K	Buy	10,753 +1,533	+17%	+$37.1K	﹤0.01%	1942
2021 Q4	$216K	Sell	9,220 -85,059	-90%	-$1.71M	﹤0.01%	2005
2021 Q3	$1.57M	Buy	94,279 +14,666	+18%	+$283K	0.01%	1178
2021 Q2	$1.94M	Buy	79,613 +1,380	+2%	+$31.1K	0.01%	1116
2021 Q1	$2.02M	Buy	78,233 +22,996	+42%	+$1.01M	0.01%	1024
2020 Q4	$2.95M	Sell	55,237 -23,009	-29%	-$1.14M	0.02%	797
2020 Q3	$3.23M	Sell	78,246 -10,705	-12%	-$462K	0.02%	701
2020 Q2	$4.31M	Buy	88,951 +7,482	+9%	+$359K	0.03%	581
2020 Q1	$3.44M	Sell	81,469 -17,902	-18%	-$738K	0.04%	593
2019 Q4	$4.25M	Buy	99,371 +15,417	+18%	+$671K	0.03%	700
2019 Q3	$3.02M	Sell	83,954 -30,155	-26%	-$914K	0.02%	842
2019 Q2	$3.05M	Sell	114,109 -15,298	-12%	-$391K	0.02%	860
2019 Q1	$3.48M	Sell	129,407 -32,762	-20%	-$765K	0.03%	804
2018 Q4	$2.62M	Sell	162,169 -3,765	-2%	-$73.1K	0.02%	910
2018 Q3	$3.44M	Sell	165,934 -7,364	-4%	-$116K	0.02%	942
2018 Q2	$2.65M	Buy	173,298 +18,749	+12%	+$334K	0.02%	1080
2018 Q1	$3.47M	Buy	154,549 +8,437	+6%	+$234K	0.01%	1244
2017 Q4	$4.4M	Sell	146,112 -16,151	-10%	-$516K	0.01%	1107
2017 Q3	$6.11M	Sell	162,263 -9,373	-5%	-$305K	0.02%	943
2017 Q2	$4.79M	Buy	171,636 +45,128	+36%	+$1.34M	0.01%	1043
2017 Q1	$4.35M	Sell	126,508 -8,842	-7%	-$312K	0.01%	1108
2016 Q4	$3.9M	Buy	135,350 +5,472	+4%	+$145K	0.01%	1156
2016 Q3	$4.13M	Buy	129,878 +8,083	+7%	+$274K	0.01%	1129
2016 Q2	$3.95M	Sell	121,795 -49,802	-29%	-$1.67M	0.01%	1117
2016 Q1	$4.8M	Sell	171,597 -21,063	-11%	-$459K	0.02%	1009
2015 Q4	$6.87M	Sell	192,660 -43,601	-18%	-$1.54M	0.02%	892
2015 Q3	$7.81M	Sell	236,261 -35,914	-13%	-$1.49M	0.02%	847
2015 Q2	$11.4M	Buy	272,175 +11,261	+4%	+$436K	0.03%	781
2015 Q1	$8.5M	Buy	260,914 +38,102	+17%	+$1.31M	0.02%	926
2014 Q4	$7.07M	Buy	222,812 +30,632	+16%	+$869K	0.02%	968
2014 Q3	$4.76M	Sell	192,180 -4,576	-2%	-$107K	0.01%	1228
2014 Q2	$4.45M	Sell	196,756 -26,473	-12%	-$553K	0.01%	1255
2014 Q1	$5.43M	Buy	223,229 +26,824	+14%	+$679K	0.02%	1076
2013 Q4	$4.91M	Buy	196,405 +7,347	+4%	+$173K	0.02%	1102
2013 Q3	$5.19M	Sell	189,058 -106,814	-36%	-$2.23M	0.02%	1080
2013 Q2	$5.37M	Buy	+295,872	New	+$4.08M	0.02%	1020